Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Some drugs may help treat both COVID-19 and radiation injury.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Yes, smoking damages your skin.

Some natural ingredients like onion juice, rosemary oil, and pumpkin seed oil may help with hair growth and reducing hair loss.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.